Choose  Experience.
What is High Intensity Focused Ultrasound (HIFU)?

High Intensity Focused Ultrasound or HIFU, is FDA approved for the treatment of prostate cancer. HIFU destroys prostate tissue with heat which essentially “cooks” the tissue. Ultrasound energy or sound waves are focused at a focal point in the prostate about the size of a grain of rice. This area is heated to 198 ºF for 3 seconds destroying tissue within the focal point. The computer guides the ultrasound probe to the adjacent focal point and is treated. The process continues until the entire prostate is destroyed thus killing the cancer.

Advantages of HIFU:
  • No blood loss

  • Quick recovery

  • Non-surgical

  • Radiation-free

  • An outpatient procedure

  • Can be performed while patient is on blood thinners

  • Takes only one to four hours, depending on prostate size

  • Performed as an out-patient procedure under a spinal (epidural) anesthesia

  • Recovery time is minimal

  • Patients are usually up and walking around within hours after the procedure and may return to a normal lifestyle within a couple of days

  • A catheter is inserted during the procedure and usually worn for one to four weeks

Ablatherm® HIFU
HIFU is Precise and Controlled

The Ablatherm® HIFU is a non invasive treatment for localized prostate cancer.  Rather than using surgery or radiation, this treatment uses High Intensity Focused Ultrasound energy (sound waves) to destroy targeted areas of the prostate.   HIFU is one of the latest, state-of-the-art technologies using heat to destroy prostate tissue with pinpoint accuracy, leading to fewer side effects and a quicker recovery time.  As the procedure is non-invasive, the HIFU patient can usually return to normal activity after only a few days.

The Ablatherm® obtains real-time ultrasound images of the prostate and surrounding areas. From these images, the doctor plans where the ultrasound energy will be delivered. The Ablatherm® software allows the surgeon to visually direct the treatment and precisely define the treatment zones in order to destroy the entire gland or selected portions (focal therapy).


Unlike radiation, HIFU is non-ionizing so it can be repeated, if necessary, without damaging healthy tissue. This means that HIFU can also be used as a salvage technique if other prostate cancer treatments fail.​

Who is a Candidate for HIFU with the Ablatherm®?

Primary Diagnosis

Ablatherm® HIFU is most effective for men who have early stage, localized prostate cancer that has not spread or metastasized outside the prostate. However, it is recommended that you discuss your individual medical records and history with a physician in order to confirm whether or not you are a candidate for HIFU.


HIFU for Recurrent Prostate Cancer

Many patients who have had radiation therapy, brachytherapy or external beam radiation and experience a rise in PSA have discovered that the cancer is back. These patients may be candidates for HIFU as well, as long as the cancer has not spread to the bone or other organs.

Additionally, patients who have a local recurrence after receiving a radical prostatectomy may qualify for HIFU.

HIFU has therapeutic advantages over traditional prostate cancer therapies.